Literature DB >> 10352175

hPop4: a new protein subunit of the human RNase MRP and RNase P ribonucleoprotein complexes.

H van Eenennaam1, G J Pruijn, W J van Venrooij.   

Abstract

RNase MRP is a ribonucleoprotein particle involved in the processing of pre-rRNA. The RNase MRP particle is structurally highly related to the RNase P particle, which is involved in pre-tRNA processing. Their RNA components fold into a similar secondary structure and they share several protein subunits. We have identified and characterised human and mouse cDNAs that encode proteins homologous to yPop4p, a protein subunit of both the yeast RNase MRP and RNase P complexes. The human Pop4 cDNA encodes a highly basic protein of 220 amino acids. Transfection experiments with epitope-tagged hPop4 protein indicated that hPop4 is localised in the nucleus and accumulates in the nucleolus. Immunoprecipitation assays using extracts from transfected cells expressing epitope-tagged hPop4 revealed that this protein is associated with both the human RNase MRP and RNase P particles. Polyclonal rabbit antibodies raised against recombinant hPop4 recognised a 30 kDa protein in total HeLa cell extracts and specifically co-immunoprecipitated the RNA components of the RNase MRP and RNase P complexes. Finally we showed that anti-hPop4 immunoprecipitates possess RNase P enzymatic activity. Taken together, these data show that we have identified a protein that represents the human counterpart of the yeast Pop4p protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352175      PMCID: PMC148449          DOI: 10.1093/nar/27.12.2465

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway.

Authors:  S Xiao; F Houser-Scott; D R Engelke
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

2.  Basic domains target protein subunits of the RNase MRP complex to the nucleolus independently of complex association.

Authors:  H van Eenennaam; A van der Heijden; R J Janssen; W J van Venrooij; G J Pruijn
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

3.  Function and subnuclear distribution of Rpp21, a protein subunit of the human ribonucleoprotein ribonuclease P.

Authors:  N Jarrous; R Reiner; D Wesolowski; H Mann; C Guerrier-Takada; S Altman
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

Review 4.  Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes.

Authors:  Shaohua Xiao; Felicia Scott; Carol A Fierke; David R Engelke
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

5.  An active precursor in assembly of yeast nuclear ribonuclease P.

Authors:  Chatchawan Srisawat; Felicia Houser-Scott; Edouard Bertrand; Shaohua Xiao; Robert H Singer; David R Engelke
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

6.  Partial reconstitution of human RNase P in HeLa cells between its RNA subunit with an affinity tag and the intact protein components.

Authors:  Yong Li; Sidney Altman
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

7.  Mutual interactions between subunits of the human RNase MRP ribonucleoprotein complex.

Authors:  Tim J M Welting; Walther J van Venrooij; Ger J M Pruijn
Journal:  Nucleic Acids Res       Date:  2004-04-19       Impact factor: 16.971

Review 8.  Of proteins and RNA: the RNase P/MRP family.

Authors:  Olga Esakova; Andrey S Krasilnikov
Journal:  RNA       Date:  2010-07-13       Impact factor: 4.942

9.  A semantic analysis of the annotations of the human genome.

Authors:  Purvesh Khatri; Bogdan Done; Archana Rao; Arina Done; Sorin Draghici
Journal:  Bioinformatics       Date:  2005-06-14       Impact factor: 6.937

10.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.

Authors:  Jan Bressler; Aaron R Folsom; David J Couper; Kelly A Volcik; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.